by Oceanit | Apr 15, 2025 | Education, Future
Novavax COVID-19 Vaccine Shows Lower Reactogenicity Than mRNA As COVID-19 seasonal surges continue into 2025, vaccine options have expanded to accommodate varying public health needs and individual preferences. Among these, the Novavax COVID-19 Vaccine, Adjuvanted...
by Oceanit | Apr 11, 2025 | Future, International News
Next-Gen COVID-19 Vaccines by INOVIO, Ocugen, Pfizer in 2025 Five years into the COVID-19 pandemic, the virus continues to evolve—and so does the science behind vaccines. In 2025, leading biotechnology companies are racing to deliver next-generation COVID-19 vaccines...
by Oceanit | Apr 9, 2025 | Future, Government
Anti-Vaccine Sentiment Threatens Future FDA Vaccine Approvals As the United States moves deeper into a post-pandemic world, a new concern is emerging among scientists, public health experts, and pharmaceutical companies: the growing influence of anti-vaccine sentiment...
by Oceanit | Apr 3, 2025 | Future, National News
Novavax Delay & RFK Jr.’s Vaccine Misinformation in 2025 In April 2025, two major stories have captured attention in the ongoing conversation around COVID-19: the delayed FDA approval of the updated Novavax COVID-19 vaccine and Robert F. Kennedy Jr.’s (RFK Jr.)...
by Oceanit | Mar 24, 2025 | Education, Government
US COVID-19 Management Updates and Best Practices for April 2025 As of April 2025, the United States government continues to adapt its COVID-19 management strategies to address the evolving nature of the SARS-CoV-2 virus. Recent updates encompass vaccination...
